A new bioproduction route for a novel antimicrobial peptide

Related Experiment Video

Updated: Jun 7, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Derrick Kok Sing Tay1, Gobinath Rajagopalan, Xiang Li

  • 1School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.

Biotechnology and Bioengineering
|October 23, 2010
PubMed

Insights

Researchers developed a scalable Escherichia coli production method for human beta-defensin 28 (hBD28), a potent antimicrobial peptide. This overcomes previous scarcity issues, enabling antimicrobial and structural studies of this promising therapeutic agent.

Area of Science:

  • Biochemistry
  • Microbiology
  • Molecular Biology

Background:

  • Beta-defensins are antimicrobial peptides (AMPs) with broad-spectrum activity and low resistance potential.
  • Human beta-defensin 28 (hBD28), a cationic AMP, is hypothesized to effectively target pathogen membranes.
  • In vivo scarcity and poor chemical synthesis yields have hindered hBD28 research.

Purpose of the Study:

  • To establish a rapid, scalable, and cost-effective production route for bioactive hBD28.
  • To enable detailed structural and antimicrobial studies of hBD28.
  • To investigate the antimicrobial efficacy of recombinantly produced hBD28.

Main Methods:

  • Engineered a dual fusion tag expression construct for enhanced soluble expression in Escherichia coli.
  • Purified hBD28 to >95% purity.
  • Assessed antimicrobial activity against E. coli K12 using dose-dependent killing kinetics.
  • Utilized Circular Dichroism (CD) spectroscopy to analyze secondary structure.

Main Results:

  • Successfully developed a scalable Escherichia coli-based production system for hBD28.
  • Obtained highly pure (>95%) bioactive hBD28.
  • Demonstrated significant dose-dependent antimicrobial activity against E. coli K12.
  • CD spectroscopy confirmed the presence of beta-sheet and alpha-helix structures in hBD28.

Conclusions:

  • The developed E. coli expression system provides a viable method for producing bioactive hBD28.
  • This scalable production overcomes previous limitations, facilitating further research into hBD28's therapeutic potential.
  • Recombinant hBD28 exhibits potent antimicrobial activity, supporting its role in innate immunity and potential therapeutic applications.

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...